DATA WITH INTENTION: SUCCEEDING WITH HIGH-QUALITY, CONDITION-SPECIFIC RWD FOR RESEARCH AND REGULATORY GOALS
Author(s)
Moderator: Richard Gliklich, MD, OM1, Boston, MA, USA
Speakers: Ying Bao, MD, ScD, Bristol-Myers Squibb, Lawrenceville, NJ, USA; Gary Curhan, MD, ScD, OM1, Boston, MA, USA
When it comes to real-world evidence, it’s all about the data. But not all data are created equal and quality doesn’t happen accidentally. Real-world data (RWD) quality begins with intentionality by condition. To make it research and regulatory-grade, advanced technologies are needed to capture and process the data appropriately and with transparency. This symposium will explore:
- Defining RWD and getting to the data that matters
- Understanding what high-quality clinical data looks like and how it’s generated
- Leveraging technologies to collect, process, and normalize the data
- Use cases for applying RWD across the product lifecycle for decision making, including regulatory
Conference/Value in Health Info
2020-05, ISPOR 2020, Orlando, FL, USA